INTEGER HOLDINGS CORPORATION Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases
INTEGER HOLDINGS CORPORATION (ITGR) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases of $0 for the 3-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases · last filed 2026-08-04
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2026-07-03 was $0.00.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2026-04-03 was $0.00, a 100.00% decline year-over-year.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2025-12-31 was $7.00M.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for the quarter ending 2025-09-26 was $0.00.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2025 was $9.54M, a 166.66% increase from fiscal 2024.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2024 was $3.58M, a 308.45% increase from fiscal 2023.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2023 was $876.00K, a 88.12% decline from fiscal 2022.
- INTEGER HOLDINGS CORPORATION fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases for fiscal 2022 was $7.38M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases 12 month |
|---|---|---|---|---|
| 2026-07-03 | $0.00 10-Q · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $7.00M derived: sum of 3 quarters · filed 2026-08-04 | $7.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-04-03 | $0.00 10-Q · filed 2026-04-30 | $7.00M derived: sum of 2 quarters · filed 2026-04-30 | $7.00M derived: sum of 3 quarters · filed 2026-04-30 | $7.00M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $7.00M derived: sum of 2 quarters · filed 2026-02-23 | $7.00M derived: sum of 3 quarters · filed 2026-08-04 | $9.54M 10-K · filed 2026-02-23 |
| 2025-09-26 | $0.00 10-Q · filed 2025-10-23 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $2.54M 10-Q · filed 2025-10-23 | $2.54M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-27 | $0.00 10-Q · filed 2026-08-04 | $2.54M 10-Q · filed 2026-08-04 | $2.54M derived: sum of 3 quarters · filed 2026-08-04 | $2.54M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-28 | $2.54M 10-Q · filed 2026-04-30 | $2.54M derived: sum of 2 quarters · filed 2026-04-30 | $2.54M derived: sum of 3 quarters · filed 2026-04-30 | $2.54M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $3.58M 10-K · filed 2026-02-23 |
| 2024-09-27 | $0.00 10-Q · filed 2025-10-23 | $0.00 derived: sum of 2 quarters · filed 2025-10-23 | $3.58M 10-Q · filed 2025-10-23 | $4.45M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-28 | $0.00 10-Q · filed 2025-07-24 | $3.58M 10-Q · filed 2025-07-24 | $4.45M derived: sum of 3 quarters · filed 2026-02-23 | $4.45M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-29 | $3.58M 10-Q · filed 2025-04-24 | $4.45M derived: sum of 2 quarters · filed 2026-02-23 | $4.45M derived: sum of 3 quarters · filed 2026-02-23 | $4.45M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $876.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $876.00K derived: sum of 2 quarters · filed 2026-02-23 | $876.00K derived: sum of 3 quarters · filed 2026-02-23 | $876.00K 10-K · filed 2026-02-23 |
| 2023-09-29 | $0.00 10-Q · filed 2024-10-24 | $0.00 derived: sum of 2 quarters · filed 2024-10-24 | $0.00 10-Q · filed 2024-10-24 | $0.00 derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $0.00 10-Q · filed 2024-07-25 | $0.00 10-Q · filed 2024-07-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-20 | $0.00 derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $0.00 10-Q · filed 2024-04-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-20 | $0.00 derived: sum of 3 quarters · filed 2025-02-20 | $7.38M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $0.00 derived: sum of 2 quarters · filed 2025-02-20 | $7.38M derived: sum of 3 quarters · filed 2025-02-20 | $7.38M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-26 | $7.38M derived: sum of 2 quarters · filed 2023-10-26 | $7.38M 10-Q · filed 2023-10-26 | |
| 2022-07-01 | $7.38M 10-Q · filed 2023-07-27 | $7.38M 10-Q · filed 2023-07-27 | ||
| 2021-10-01 | $0.00 10-Q · filed 2022-10-27 | $0.00 derived: sum of 2 quarters · filed 2022-10-27 | $0.00 10-Q · filed 2022-10-27 | $0.00 derived: sum of 4 quarters · filed 2022-10-27 |
| 2021-07-02 | $0.00 10-Q · filed 2022-07-28 | $0.00 10-Q · filed 2022-07-28 | $0.00 derived: sum of 3 quarters · filed 2022-07-28 | $0.00 derived: sum of 4 quarters · filed 2022-07-28 |
| 2021-04-02 | $0.00 10-Q · filed 2021-04-29 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $0.00 derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $0.00 derived: sum of 2 quarters · filed 2022-02-22 | $0.00 derived: sum of 3 quarters · filed 2022-02-22 | $2.70M 10-K · filed 2022-02-22 |
| 2020-10-02 | $0.00 10-Q · filed 2021-10-28 | $0.00 derived: sum of 2 quarters · filed 2021-10-28 | $2.70M 10-Q · filed 2021-10-28 | |
| 2020-07-03 | $0.00 10-Q · filed 2021-07-29 | $2.70M 10-Q · filed 2021-07-29 | ||
| 2020-04-03 | $2.70M 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | $4.20M 10-K · filed 2021-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |